机构：[1]Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[2]Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.[3]Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China.
第一作者机构：[1]Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
通讯作者：
推荐引用方式(GB/T 7714)：
Wang Xueyan,Liu Xiaowei,Hugo Willy,et al.Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments[J].Frontiers in immunology.2022,13:1065937.doi:10.3389/fimmu.2022.1065937.
APA：
Wang Xueyan,Liu Xiaowei,Hugo Willy,Si Lu&Shi Hubing.(2022).Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments.Frontiers in immunology,13,
MLA：
Wang Xueyan,et al."Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments".Frontiers in immunology 13.(2022):1065937
医学